INVEX THERAPEUTICS LTD - Announcements

10.0%

11.0¢

Market Cap $8.266M

Healthcare Biotechnology

Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical... Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Our primary focus is on the orphan disease Idiopathic Intracranial Hypertension (IIH), a large and growing market opportunity with no regulatory cleared treatmentsMore

ASX:PAR

This stock could have something close to a cure for osteoarthritis. Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.

Announcements

Filter Results

All Price Sensitive Only

IXC	Results of Meeting		30/06/20	44.81KB	Share
IXC	Presentation of Exenatide Phase II Data at Headache Congress		29/06/20	221.06KB	Share
IXC	Change in substantial holding		02/06/20	300.98KB	Share
IXC	Ceasing to be a substantial holder		02/06/20	1.06MB	Share
IXC	Change of Director's Interest Notice		02/06/20	323.36KB	Share
IXC	Postcard to Shareholders - General Meeting		28/05/20	859.24KB	Share
IXC	Notice of General Meeting/Proxy Form		28/05/20	983.34KB	Share
IXC	Change in substantial holding		28/05/20	224.49KB	Share
IXC	Ceasing to be a substantial holder		28/05/20	556.86KB	Share
IXC	Change in substantial holding		28/05/20	1.15MB	Share
IXC	Change in substantial holding		28/05/20	243.48KB	Share
IXC	Issue of Tranche 1 Placement Shares and Appendix 2A		28/05/20	568.44KB	Share
IXC	Proposed issue of Securities - IXC		22/05/20	25.46KB	Share
IXC	Proposed issue of Securities - IXC		22/05/20	25.71KB	Share
IXC	Phase II Clinical Results and Capital Raising Presentation	PRICE SENSITIVE	22/05/20	1.01MB	Share
IXC	Succesful $26 million Share Placement	PRICE SENSITIVE	22/05/20	252.04KB	Share
IXC	Exenatide Meets Key Endpoints in IIH Clinical Trial	PRICE SENSITIVE	20/05/20	569.52KB	Share
IXC	Trading Halt	PRICE SENSITIVE	18/05/20	374.82KB	Share
IXC	Virtual Health Conference Presentation		01/05/20	440.35KB	Share
IXC	Virtual Heath Conference		29/04/20	181.48KB	Share
IXC	Phase II Clinical Trial Update		23/04/20	237.3KB	Share
IXC	Appendix 3G - Issue of Options		14/04/20	392.02KB	Share
IXC	Quarterly Report and Appendix 4C	PRICE SENSITIVE	02/04/20	382.7KB	Share
IXC	Appendix 2A		30/03/20	487.05KB	Share
IXC	Investor Presentation		09/03/20	593.75KB	Share
IXC	Appendix 4D and Half-year Report	PRICE SENSITIVE	27/02/20	397.41KB	Share
IXC	Appendix 3B		28/01/20	532.39KB	Share
IXC	Appendix 3B		21/01/20	577.36KB	Share
IXC	Appendix 4C - quarterly	PRICE SENSITIVE	17/01/20	321.22KB	Share
IXC	Completion of Exenatide Phase II Clinical Trial		13/01/20	177.3KB	Share
IXC	Change of Director's Interest Notice x4		22/11/19	315.35KB	Share
IXC	Appendix 3B		22/11/19	562.21KB	Share
IXC	Results of Meeting		21/11/19	213.21KB	Share
IXC	Open Briefing Presentation		19/11/19	978.58KB	Share
IXC	Invitation to Open Briefing		28/10/19	149.15KB	Share
IXC	Appendix 4C - quarterly	PRICE SENSITIVE	17/10/19	285.38KB	Share
IXC	Phase II Recruitment Completed	PRICE SENSITIVE	15/10/19	148.82KB	Share
IXC	Japanese Patent Granted	PRICE SENSITIVE	07/10/19	145.83KB	Share
IXC	Notice of Annual General Meeting/Proxy Form		03/10/19	1.17MB	Share
IXC	Phase II Trial Update		11/09/19	145.37KB	Share
IXC	Appendix 4G		29/08/19	206.7KB	Share
IXC	Preliminary Final Report	PRICE SENSITIVE	28/08/19	531.12KB	Share
IXC	Appendix 4C - quarterly	PRICE SENSITIVE	24/07/19	302.05KB	Share
IXC	Invex Therapeutics Lists on ASX		05/07/19	167.68KB	Share
IXC	Investor Presentation		05/07/19	828.12KB	Share
IXC	Becoming a substantial holder		05/07/19	95.65KB	Share
IXC	Becoming a substantial holder		05/07/19	142.19KB	Share
IXC	Becoming a substantial holder		05/07/19	1.07MB	Share
IXC	Becoming a substantial holder		05/07/19	1.4MB	Share
IXC	Becoming a substantial holder		05/07/19	82.11KB	Share
IXC	Initial Director's Interest Notice x4		05/07/19	262.4KB	Share
IXC	Becoming a substantial holder		05/07/19	83.51KB	Share
IXC	Capital Structure		03/07/19	150.06KB	Share
IXC	Restricted Securities		03/07/19	209.66KB	Share
IXC	Securities Trading Policy		03/07/19	317.35KB	Share
IXC	Incentive Option Plan Terms		03/07/19	280.52KB	Share
IXC	Confirmation Statements		03/07/19	152.2KB	Share
IXC	Updated Pro-Forma		03/07/19	237.4KB	Share
IXC	Updated Commitments		03/07/19	185.75KB	Share
IXC	Financial Statements		03/07/19	584.22KB	Share
IXC	Constitution		03/07/19	436.03KB	Share
IXC	Replacement Prospectus		03/07/19	5.13MB	Share
IXC	Appendix 1A and Information Form and Checklist		03/07/19	466.85KB	Share
IXC	Top 20 Holders		03/07/19	74.64KB	Share
IXC	Distribution Schedule		03/07/19	72.58KB	Share
IXC	ASX Notice - Admission to Official List		03/07/19	89.46KB	Share

IXC Results of Meeting
30/06/20		44.81KB	Share
IXC Presentation of Exenatide Phase II Data at Headache Congress
29/06/20		221.06KB	Share
IXC Change in substantial holding
02/06/20		300.98KB	Share
IXC Ceasing to be a substantial holder
02/06/20		1.06MB	Share
IXC Change of Director's Interest Notice
02/06/20		323.36KB	Share
IXC Postcard to Shareholders - General Meeting
28/05/20		859.24KB	Share
IXC Notice of General Meeting/Proxy Form
28/05/20		983.34KB	Share
IXC Change in substantial holding
28/05/20		224.49KB	Share
IXC Ceasing to be a substantial holder
28/05/20		556.86KB	Share
IXC Change in substantial holding
28/05/20		1.15MB	Share
IXC Change in substantial holding
28/05/20		243.48KB	Share
IXC Issue of Tranche 1 Placement Shares and Appendix 2A
28/05/20		568.44KB	Share
IXC Proposed issue of Securities - IXC
22/05/20		25.46KB	Share
IXC Proposed issue of Securities - IXC
22/05/20		25.71KB	Share
IXC Phase II Clinical Results and Capital Raising Presentation
22/05/20	PRICE SENSITIVE	1.01MB	Share
IXC Succesful $26 million Share Placement
22/05/20	PRICE SENSITIVE	252.04KB	Share
IXC Exenatide Meets Key Endpoints in IIH Clinical Trial
20/05/20	PRICE SENSITIVE	569.52KB	Share
IXC Trading Halt
18/05/20	PRICE SENSITIVE	374.82KB	Share
IXC Virtual Health Conference Presentation
01/05/20		440.35KB	Share
IXC Virtual Heath Conference
29/04/20		181.48KB	Share
IXC Phase II Clinical Trial Update
23/04/20		237.3KB	Share
IXC Appendix 3G - Issue of Options
14/04/20		392.02KB	Share
IXC Quarterly Report and Appendix 4C
02/04/20	PRICE SENSITIVE	382.7KB	Share
IXC Appendix 2A
30/03/20		487.05KB	Share
IXC Investor Presentation
09/03/20		593.75KB	Share
IXC Appendix 4D and Half-year Report
27/02/20	PRICE SENSITIVE	397.41KB	Share
IXC Appendix 3B
28/01/20		532.39KB	Share
IXC Appendix 3B
21/01/20		577.36KB	Share
IXC Appendix 4C - quarterly
17/01/20	PRICE SENSITIVE	321.22KB	Share
IXC Completion of Exenatide Phase II Clinical Trial
13/01/20		177.3KB	Share
IXC Change of Director's Interest Notice x4
22/11/19		315.35KB	Share
IXC Appendix 3B
22/11/19		562.21KB	Share
IXC Results of Meeting
21/11/19		213.21KB	Share
IXC Open Briefing Presentation
19/11/19		978.58KB	Share
IXC Invitation to Open Briefing
28/10/19		149.15KB	Share
IXC Appendix 4C - quarterly
17/10/19	PRICE SENSITIVE	285.38KB	Share
IXC Phase II Recruitment Completed
15/10/19	PRICE SENSITIVE	148.82KB	Share
IXC Japanese Patent Granted
07/10/19	PRICE SENSITIVE	145.83KB	Share
IXC Notice of Annual General Meeting/Proxy Form
03/10/19		1.17MB	Share
IXC Phase II Trial Update
11/09/19		145.37KB	Share
IXC Appendix 4G
29/08/19		206.7KB	Share
IXC Preliminary Final Report
28/08/19	PRICE SENSITIVE	531.12KB	Share
IXC Appendix 4C - quarterly
24/07/19	PRICE SENSITIVE	302.05KB	Share
IXC Invex Therapeutics Lists on ASX
05/07/19		167.68KB	Share
IXC Investor Presentation
05/07/19		828.12KB	Share
IXC Becoming a substantial holder
05/07/19		95.65KB	Share
IXC Becoming a substantial holder
05/07/19		142.19KB	Share
IXC Becoming a substantial holder
05/07/19		1.07MB	Share
IXC Becoming a substantial holder
05/07/19		1.4MB	Share
IXC Becoming a substantial holder
05/07/19		82.11KB	Share
IXC Initial Director's Interest Notice x4
05/07/19		262.4KB	Share
IXC Becoming a substantial holder
05/07/19		83.51KB	Share
IXC Capital Structure
03/07/19		150.06KB	Share
IXC Restricted Securities
03/07/19		209.66KB	Share
IXC Securities Trading Policy
03/07/19		317.35KB	Share
IXC Incentive Option Plan Terms
03/07/19		280.52KB	Share
IXC Confirmation Statements
03/07/19		152.2KB	Share
IXC Updated Pro-Forma
03/07/19		237.4KB	Share
IXC Updated Commitments
03/07/19		185.75KB	Share
IXC Financial Statements
03/07/19		584.22KB	Share
IXC Constitution
03/07/19		436.03KB	Share
IXC Replacement Prospectus
03/07/19		5.13MB	Share
IXC Appendix 1A and Information Form and Checklist
03/07/19		466.85KB	Share
IXC Top 20 Holders
03/07/19		74.64KB	Share
IXC Distribution Schedule
03/07/19		72.58KB	Share
IXC ASX Notice - Admission to Official List
03/07/19		89.46KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 11.0¢		Change 0.010(10.0%)		Mkt cap ! $8.266M

Open	High	Low	Value	Volume
11.0¢	11.0¢	11.0¢	$2.306K	20.96K

Buyers (Bids)

No.	Vol.	Price($)
2	51528	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	4039	1

View Market Depth

No.	Vol.	Price($)
2	51528	0.095
1	100000	0.091
1	50000	0.087
1	50000	0.085
1	38671	0.075

Price($)	Vol.	No.
0.110	4039	1
0.145	2000	1
0.150	713	1
0.000	0	0
0.000	0	0

Last trade - 16.10pm 16/09/2025 (20 minute delay)

IXC (ASX) Chart

INVEX THERAPEUTICS LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories